.png){kind=icon}
.png){kind=icon}
Return
EZH2 inhibitor tazemetostat voluntarily withdrawn from market
.png){kind=icon}
OA
AI
L
DOI：10.1002/cncr.70454.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.1
Papers:
2.0W
Citations:
6.2W
Organization
No organization information available
Cited Papers